Curis Lifesciences Reports H1 FY'27 Results Following Key Strategic Acquisitions
Curis Lifesciences Ltd · Others (Uncategorized) · 16 Nov 2026, 4:54 pm
Curis Lifesciences Reports H1 FY'27 Results Following Key Strategic Acquisitions Curis Lifesciences approved unaudited financial results for the half year ended 30th Sep'26. On a consolidated basis, revenue from operations reached ₹3,703.39 lakh, with total income at ₹3,748.95 lakh and profit attributable to owners at ₹413.98 lakh (EPS: ₹5.76). Standalone revenue rose to ₹3,411.94 lakh from ₹2,790.89 lakh YoY, while standalone net profit stood at ₹413.50 lakh versus ₹421.09 lakh YoY. During the period, the company acquired a 51% stake in Uninova Lifesciences and a 49.95% stake in Nigeria-based Curosun Pharmaceutical.
Original exchange filing (PDF)
More announcements from Curis Lifesciences Ltd
- Curis Lifesciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 11 Nov 2026
- Curis Lifesciences Limited has submitted to the Exchange, the standalone and consolidated financial results for the half year ended September 30, 2026. · 11 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 11 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about the Board meeting to be held on 11th November, 2026 to consider and approve the unaudited Standalone and Consolidated financial results for the half year ended on September 30, 2026 · 11 Nov 2026
- Curis Lifesciences Limited has informed regarding Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Quarter and year ended on September 30, 2026 · 19 Oct 2026
- Curis Lifesciences Limited has submitted the Exchange a copy Srutinizers report of 10th Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results. · 01 Oct 2026
- CURIS: Curis Lifesciences Limited has informed the Exchange regarding Proceedings of 10thAnnual General Meeting held on September 29, 2026. · 30 Sept 2026
- Curis Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026 · 08 Sept 2026
